UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000003965
Receipt No. R000004756
Scientific Title The role of TRIM family in rheumatic diseases and aquired immunodeficiency syndrome
Date of disclosure of the study information 2010/08/01
Last modified on 2018/02/01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The role of TRIM family in rheumatic diseases and aquired immunodeficiency syndrome
Acronym The role of TRIM family in rheumatic diseases and aquired immunodeficiency syndrome
Scientific Title The role of TRIM family in rheumatic diseases and aquired immunodeficiency syndrome
Scientific Title:Acronym The role of TRIM family in rheumatic diseases and aquired immunodeficiency syndrome
Region
Japan

Condition
Condition Behcet disease
Systemic lupus erythematosus
Sjogren's syndrome
HIV infection
Classification by specialty
Clinical immunology Infectious disease
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the difference in expression and functions of TRIM family proteins among the rheumatic diseases and their change by disease activity.
Basic objectives2 Bio-availability
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes Expression levels of TRIM family genes
Expression levels of cytokine genes
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
16 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with Behcet disease, SLE, Sjogren's syndrome, HIV infection
Healthy control
Key exclusion criteria none
Target sample size 300

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Ryusuke Yoshimi
Organization Yokohama City University Graduate School of Medicine
Division name Department of Hematology and Clinical Immunology
Zip code
Address 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, Japan
TEL 045-787-2630
Email yoshiryu@med.yokohama-cu.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Ryusuke Yoshimi
Organization Yokohama City University Graduate School of Medicine
Division name Department of Hematology and Clinical Immunology
Zip code
Address 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, Japan
TEL 045-787-2630
Homepage URL
Email yoshiryu@med.yokohama-cu.ac.jp

Sponsor
Institute Department of Hematology and Clinical Immunology
Yokohama City University Graduate School of Medicine
Institute
Department

Funding Source
Organization Takeda Science Foundation
Mochida Memorial Foundation for Medical and Pharmaceutical Research
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 横浜市立大学附属病院(神奈川県)
血液・リウマチ・感染症内科
Department of Hematology and Clinical Immunology
Yokohama City University Graduate School of Medicine

Other administrative information
Date of disclosure of the study information
2010 Year 08 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2010 Year 07 Month 02 Day
Date of IRB
Anticipated trial start date
2010 Year 08 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information We investigate expression levels of TRIM family and cytokine genes.

Management information
Registered date
2010 Year 07 Month 28 Day
Last modified on
2018 Year 02 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004756

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.